ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Bispecific antibody builder Abpro postpones $69M IPO
May 16, 2018The early-stage biotech Abpro has postponed its $69 million IPO, according to a report from Renaissance Capital, delaying a capital infusion it hoped would support the first clinical trials of its lead product candidates over the next year -
3 Biotechs Seeking $271M IPO in the New Year
January 03, 2018Individuals aren’t the only ones making New Year’s Resolutions. Three biotech companies want to start out the new year with a new start—as publicly traded companies. -
Rhythm Pharma strikes a chord with oversubscribed $120M IPO
October 09, 2017Rhythm Pharmaceuticals has topped its expectations in its IPO, selling more shares—at a higher price—than expected when it announced its intention to go public a few weeks back.
Pharma Sources Insight January 2025
